| Ranibizumab therapy for neovascular age-related macular degeneration. | |
| | |
MedLine Citation:
|
PMID: 20961248 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
James C Folk; Edwin M Stone |
Related Documents
:
|
3897938 - Clinicopathological correlation of a solitary choroidal tuberculoma. 19996828 - Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone ... 9428018 - Dye extravasation and the nature of background fluorescence in sodium fluorescein angio... 16531278 - Experimental inhibition of corneal neovascularization by photodynamic therapy with vert... 18645338 - Do sleep disorders have an impact on blood pressure? 20598508 - The effect of age and sex on facial mimicry: a three-dimensional study in healthy adults. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: The New England journal of medicine Volume: 363 ISSN: 1533-4406 ISO Abbreviation: N. Engl. J. Med. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-21 Completed Date: 2010-10-28 Revised Date: 2011-02-11 |
Medline Journal Info:
|
Nlm Unique ID: 0255562 Medline TA: N Engl J Med Country: United States |
Other Details:
|
Languages: eng Pagination: 1648-55 Citation Subset: AIM; IM |
Affiliation:
|
Department of Ophthalmology and Visual Sciences, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angiogenesis Inhibitors / adverse effects, therapeutic use* Antibodies, Monoclonal / adverse effects, therapeutic use* Choroidal Neovascularization Humans Injections, Intraocular / adverse effects Male Practice Guidelines as Topic Vascular Endothelial Growth Factor A / antagonists & inhibitors* Wet Macular Degeneration / drug therapy*, physiopathology |
| Grant Support | |
ID/Acronym/Agency:
|
EY016822/EY/NEI NIH HHS; //Howard Hughes Medical Institute |
| Chemical | |
Reg. No./Substance:
|
0/Angiogenesis Inhibitors; 0/Antibodies, Monoclonal; 0/Vascular Endothelial Growth Factor A; 0/bevacizumab; 0/ranibizumab |
| Comments/Corrections | |
Comment In:
|
N Engl J Med. 2011 Feb 10;364(6):582
[PMID:
21306263
]
N Engl J Med. 2011 Feb 10;364(6):581-2 [PMID: 21306264 ] |
Erratum In:
|
N Engl J Med. 2010 Dec 16;363(25):2474 Note: Dosage error in article text |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mutant CHUK and severe fetal encasement malformation.
Next Document: Treatment possibilities for retinitis pigmentosa.